25 XP   0   0   10

Aspen Pharmacare Holdings Ltd
Buy, Hold or Sell?

Let's analyse Aspen Pharmacare Holdings Ltd together

PenkeI guess you are interested in Aspen Pharmacare Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aspen Pharmacare Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Aspen Pharmacare Holdings Ltd

I send you an email if I find something interesting about Aspen Pharmacare Holdings Ltd.

Quick analysis of Aspen Pharmacare Holdings Ltd (30 sec.)










What can you expect buying and holding a share of Aspen Pharmacare Holdings Ltd? (30 sec.)

How much money do you get?

How much money do you get?
R0.68
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
R19,412.12
Expected worth in 1 year
R34,418.64
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
R16,316.63
Return On Investment
75.3%

For what price can you sell your share?

Current Price per Share
R21,672.00
Expected price per share
R20,589 - R
How sure are you?
50%

1. Valuation of Aspen Pharmacare Holdings Ltd (5 min.)




Live pricePrice per Share (EOD)

R21,672.00

Intrinsic Value Per Share

R-4,708.22 - R13,261.94

Total Value Per Share

R14,703.90 - R32,674.05

2. Growth of Aspen Pharmacare Holdings Ltd (5 min.)




Is Aspen Pharmacare Holdings Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$4.4b$3.6b$796.8m17.7%

How much money is Aspen Pharmacare Holdings Ltd making?

Current yearPrevious yearGrowGrow %
Making money$272.3m$338m-$65.6m-24.1%
Net Profit Margin12.8%16.8%--

How much money comes from the company's main activities?

3. Financial Health of Aspen Pharmacare Holdings Ltd (5 min.)




What can you expect buying and holding a share of Aspen Pharmacare Holdings Ltd? (5 min.)

Welcome investor! Aspen Pharmacare Holdings Ltd's management wants to use your money to grow the business. In return you get a share of Aspen Pharmacare Holdings Ltd.

What can you expect buying and holding a share of Aspen Pharmacare Holdings Ltd?

First you should know what it really means to hold a share of Aspen Pharmacare Holdings Ltd. And how you can make/lose money.

Speculation

The Price per Share of Aspen Pharmacare Holdings Ltd is R21,672. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aspen Pharmacare Holdings Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aspen Pharmacare Holdings Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is R19,412.12. Based on the TTM, the Book Value Change Per Share is R3,751.63 per quarter. Based on the YOY, the Book Value Change Per Share is R1,284.36 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is R327.53 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aspen Pharmacare Holdings Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 R% of Price per ShareR% of Price per ShareR% of Price per ShareR% of Price per ShareR% of Price per Share
Usd Eps0.610.0%0.610.0%0.750.0%0.640.0%0.610.0%
Usd Book Value Change Per Share1.950.0%1.950.0%0.670.0%0.880.0%0.750.0%
Usd Dividend Per Share0.170.0%0.170.0%0.140.0%0.150.0%0.130.0%
Usd Total Gains Per Share2.130.0%2.130.0%0.810.0%1.030.0%0.880.0%
Usd Price Per Share9.57-9.57-7.24-7.59-11.96-
Price to Earnings Ratio15.60-15.60-9.71-12.37-20.42-
Price-to-Total Gains Ratio4.50-4.50-8.98--1.03-14.61-
Price to Book Ratio0.95-0.95-0.89-0.95-2.36-
Price-to-Total Gains Ratio4.50-4.50-8.98--1.03-14.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.291112
Number of shares88
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.170.15
Usd Book Value Change Per Share1.950.88
Usd Total Gains Per Share2.131.03
Gains per Quarter (88 shares)187.0290.47
Gains per Year (88 shares)748.08361.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16068873852309352
212013761486105619714
3180206422341579281076
42402752298221012381438
53003440373026215471800
63604128447831518572162
74204816522636721662524
84815504597442024752886
95416192672247227853248
106016880747052530943610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%20.01.00.095.2%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.01.095.2%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%20.01.00.095.2%

Fundamentals of Aspen Pharmacare Holdings Ltd

About Aspen Pharmacare Holdings Ltd

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Fundamental data was last updated by Penke on 2024-04-19 06:24:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Aspen Pharmacare Holdings Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aspen Pharmacare Holdings Ltd earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Aspen Pharmacare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 12.8% means that 0.13 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aspen Pharmacare Holdings Ltd:

  • The MRQ is 12.8%. The company is making a huge profit. +2
  • The TTM is 12.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.8%TTM12.8%0.0%
TTM12.8%YOY16.8%-4.0%
TTM12.8%5Y11.9%+0.9%
5Y11.9%10Y13.0%-1.0%
1.1.2. Return on Assets

Shows how efficient Aspen Pharmacare Holdings Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aspen Pharmacare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.9% Return on Assets means that Aspen Pharmacare Holdings Ltd generated 0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aspen Pharmacare Holdings Ltd:

  • The MRQ is 3.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.9%TTM3.9%0.0%
TTM3.9%YOY5.8%-1.9%
TTM3.9%5Y3.8%+0.0%
5Y3.8%10Y4.4%-0.6%
1.1.3. Return on Equity

Shows how efficient Aspen Pharmacare Holdings Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aspen Pharmacare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.1% Return on Equity means Aspen Pharmacare Holdings Ltd generated 0.06 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aspen Pharmacare Holdings Ltd:

  • The MRQ is 6.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.1%TTM6.1%0.0%
TTM6.1%YOY9.1%-3.1%
TTM6.1%5Y6.6%-0.5%
5Y6.6%10Y9.9%-3.4%

1.2. Operating Efficiency of Aspen Pharmacare Holdings Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aspen Pharmacare Holdings Ltd is operating .

  • Measures how much profit Aspen Pharmacare Holdings Ltd makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aspen Pharmacare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 21.6% means the company generated 0.22  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aspen Pharmacare Holdings Ltd:

  • The MRQ is 21.6%. The company is operating efficient. +1
  • The TTM is 21.6%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.6%TTM21.6%0.0%
TTM21.6%YOY23.3%-1.7%
TTM21.6%5Y23.0%-1.4%
5Y23.0%10Y23.3%-0.3%
1.2.2. Operating Ratio

Measures how efficient Aspen Pharmacare Holdings Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.78 means that the operating costs are 0.78 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Aspen Pharmacare Holdings Ltd:

  • The MRQ is 0.780. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.780. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.780TTM0.7800.000
TTM0.780YOY0.771+0.009
TTM0.7805Y0.767+0.013
5Y0.76710Y0.765+0.002

1.3. Liquidity of Aspen Pharmacare Holdings Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aspen Pharmacare Holdings Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.92 means the company has 1.92 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Aspen Pharmacare Holdings Ltd:

  • The MRQ is 1.922. The company is able to pay all its short-term debts. +1
  • The TTM is 1.922. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.922TTM1.9220.000
TTM1.922YOY1.477+0.445
TTM1.9225Y1.625+0.297
5Y1.62510Y1.586+0.039
1.3.2. Quick Ratio

Measures if Aspen Pharmacare Holdings Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aspen Pharmacare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.06 means the company can pay off 1.06 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aspen Pharmacare Holdings Ltd:

  • The MRQ is 1.060. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.060. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.060TTM1.0600.000
TTM1.060YOY0.903+0.157
TTM1.0605Y0.930+0.130
5Y0.93010Y0.903+0.027

1.4. Solvency of Aspen Pharmacare Holdings Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aspen Pharmacare Holdings Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aspen Pharmacare Holdings Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.36 means that Aspen Pharmacare Holdings Ltd assets are financed with 35.8% credit (debt) and the remaining percentage (100% - 35.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aspen Pharmacare Holdings Ltd:

  • The MRQ is 0.358. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.358. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.358TTM0.3580.000
TTM0.358YOY0.363-0.005
TTM0.3585Y0.432-0.074
5Y0.43210Y0.527-0.095
1.4.2. Debt to Equity Ratio

Measures if Aspen Pharmacare Holdings Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aspen Pharmacare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 55.7% means that company has 0.56 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aspen Pharmacare Holdings Ltd:

  • The MRQ is 0.557. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.557. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.557TTM0.5570.000
TTM0.557YOY0.570-0.013
TTM0.5575Y0.796-0.239
5Y0.79610Y1.223-0.427

2. Market Valuation of Aspen Pharmacare Holdings Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Aspen Pharmacare Holdings Ltd generates.

  • Above 15 is considered overpriced but always compare Aspen Pharmacare Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 15.60 means the investor is paying 15.60 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aspen Pharmacare Holdings Ltd:

  • The EOD is 18.415. Based on the earnings, the company is fair priced.
  • The MRQ is 15.603. Based on the earnings, the company is fair priced.
  • The TTM is 15.603. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD18.415MRQ15.603+2.813
MRQ15.603TTM15.6030.000
TTM15.603YOY9.708+5.895
TTM15.6035Y12.369+3.233
5Y12.36910Y20.421-8.052
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aspen Pharmacare Holdings Ltd:

  • The EOD is 41.161. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 34.874. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 34.874. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD41.161MRQ34.874+6.287
MRQ34.874TTM34.8740.000
TTM34.874YOY23.528+11.346
TTM34.8745Y22.184+12.691
5Y22.18410Y60.397-38.214
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aspen Pharmacare Holdings Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Aspen Pharmacare Holdings Ltd:

  • The EOD is 1.116. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.946. Based on the equity, the company is cheap. +2
  • The TTM is 0.946. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.116MRQ0.946+0.171
MRQ0.946TTM0.9460.000
TTM0.946YOY0.888+0.058
TTM0.9465Y0.951-0.005
5Y0.95110Y2.357-1.406
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Aspen Pharmacare Holdings Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3751.6313751.6310%1284.363+192%1687.200+122%1441.265+160%
Book Value Per Share--19412.11619412.1160%15660.486+24%15297.932+27%12003.278+62%
Current Ratio--1.9221.9220%1.477+30%1.625+18%1.586+21%
Debt To Asset Ratio--0.3580.3580%0.363-1%0.432-17%0.527-32%
Debt To Equity Ratio--0.5570.5570%0.570-2%0.796-30%1.223-54%
Dividend Per Share--327.527327.5270%264.018+24%286.077+14%254.495+29%
Eps--1176.8471176.8470%1432.230-18%1219.928-4%1172.476+0%
Free Cash Flow Per Share--526.520526.5200%590.949-11%722.225-27%521.449+1%
Free Cash Flow To Equity Per Share--431.976431.9760%-441.280+202%-1184.640+374%125.585+244%
Gross Profit Margin--0.4410.4410%0.551-20%0.170+159%0.102+332%
Intrinsic Value_10Y_max--13261.936--------
Intrinsic Value_10Y_min---4708.218--------
Intrinsic Value_1Y_max--854.948--------
Intrinsic Value_1Y_min--273.809--------
Intrinsic Value_3Y_max--2930.008--------
Intrinsic Value_3Y_min--181.772--------
Intrinsic Value_5Y_max--5440.599--------
Intrinsic Value_5Y_min---611.972--------
Market Cap9627526282752.000+15%8157098449792.0008157098449792.0000%6298512000000.000+30%6598157689958.400+24%10448551294079.199-22%
Net Profit Margin--0.1280.1280%0.168-24%0.119+8%0.130-1%
Operating Margin--0.2160.2160%0.233-7%0.230-6%0.233-7%
Operating Ratio--0.7800.7800%0.771+1%0.767+2%0.765+2%
Pb Ratio1.116+15%0.9460.9460%0.888+7%0.951-1%2.357-60%
Pe Ratio18.415+15%15.60315.6030%9.708+61%12.369+26%20.421-24%
Price Per Share21672.000+15%18362.00018362.0000%13904.000+32%14574.200+26%22952.000-20%
Price To Free Cash Flow Ratio41.161+15%34.87434.8740%23.528+48%22.184+57%60.397-42%
Price To Total Gains Ratio5.313+15%4.5014.5010%8.980-50%-1.025+123%14.611-69%
Quick Ratio--1.0601.0600%0.903+17%0.930+14%0.903+17%
Return On Assets--0.0390.0390%0.058-33%0.038+1%0.044-12%
Return On Equity--0.0610.0610%0.091-34%0.066-8%0.099-39%
Total Gains Per Share--4079.1584079.1580%1548.381+163%1973.277+107%1695.760+141%
Usd Book Value--4492895600.0004492895600.0000%3696078200.000+22%3607768700.000+25%2839281196.000+58%
Usd Book Value Change Per Share--1.9551.9550%0.669+192%0.879+122%0.751+160%
Usd Book Value Per Share--10.11410.1140%8.159+24%7.970+27%6.254+62%
Usd Dividend Per Share--0.1710.1710%0.138+24%0.149+14%0.133+29%
Usd Eps--0.6130.6130%0.746-18%0.636-4%0.611+0%
Usd Free Cash Flow--121861900.000121861900.0000%139471700.000-13%170877580.000-29%123562444.000-1%
Usd Free Cash Flow Per Share--0.2740.2740%0.308-11%0.376-27%0.272+1%
Usd Free Cash Flow To Equity Per Share--0.2250.2250%-0.230+202%-0.617+374%0.065+244%
Usd Market Cap5015941193.314+15%4249848292.3424249848292.3420%3281524752.000+30%3437640156.468+24%5443695224.215-22%
Usd Price Per Share11.291+15%9.5679.5670%7.244+32%7.593+26%11.958-20%
Usd Profit--272378800.000272378800.0000%338024800.000-19%241566860.000+13%254258420.000+7%
Usd Revenue--2120938900.0002120938900.0000%2011372600.000+5%2027732000.000+5%1977912417.000+7%
Usd Total Gains Per Share--2.1252.1250%0.807+163%1.028+107%0.883+141%
 EOD+4 -4MRQTTM+0 -0YOY+19 -175Y+25 -1110Y+26 -10

3.2. Fundamental Score

Let's check the fundamental score of Aspen Pharmacare Holdings Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.415
Price to Book Ratio (EOD)Between0-11.116
Net Profit Margin (MRQ)Greater than00.128
Operating Margin (MRQ)Greater than00.216
Quick Ratio (MRQ)Greater than11.060
Current Ratio (MRQ)Greater than11.922
Debt to Asset Ratio (MRQ)Less than10.358
Debt to Equity Ratio (MRQ)Less than10.557
Return on Equity (MRQ)Greater than0.150.061
Return on Assets (MRQ)Greater than0.050.039
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Aspen Pharmacare Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.577
Ma 20Greater thanMa 5021,956.450
Ma 50Greater thanMa 10020,776.660
Ma 100Greater thanMa 20020,125.830
OpenGreater thanClose21,500.000
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in ZAR. All numbers in thousands.

Summary
Total Assets134,284,000
Total Liabilities48,048,000
Total Stockholder Equity86,236,000
 As reported
Total Liabilities 48,048,000
Total Stockholder Equity+ 86,236,000
Total Assets = 134,284,000

Assets

Total Assets134,284,000
Total Current Assets44,500,000
Long-term Assets89,784,000
Total Current Assets
Cash And Cash Equivalents 10,912,000
Net Receivables 13,624,000
Inventory 19,606,000
Other Current Assets 358,000
Total Current Assets  (as reported)44,500,000
Total Current Assets  (calculated)44,500,000
+/-0
Long-term Assets
Property Plant Equipment 18,897,000
Goodwill 5,596,000
Intangible Assets 63,104,000
Other Assets 3,009,000
Long-term Assets  (as reported)89,784,000
Long-term Assets  (calculated)90,606,000
+/- 822,000

Liabilities & Shareholders' Equity

Total Current Liabilities23,148,000
Long-term Liabilities24,900,000
Total Stockholder Equity86,236,000
Total Current Liabilities
Short-term Debt 7,907,000
Short Long Term Debt 7,907,000
Accounts payable 3,969,000
Other Current Liabilities 104,000
Total Current Liabilities  (as reported)23,148,000
Total Current Liabilities  (calculated)19,887,000
+/- 3,261,000
Long-term Liabilities
Long term Debt 21,375,000
Other Liabilities 3,525,000
Long-term Liabilities Other 353,000
Deferred Long Term Liability 822,000
Long-term Liabilities  (as reported)24,900,000
Long-term Liabilities  (calculated)26,075,000
+/- 1,175,000
Total Stockholder Equity
Common Stock2,017,000
Retained Earnings 58,134,000
Accumulated Other Comprehensive Income 26,433,000
Other Stockholders Equity -348,000
Total Stockholder Equity (as reported)86,236,000
Total Stockholder Equity (calculated)86,236,000
+/-0
Other
Capital Stock2,017,000
Cash and Short Term Investments 10,912,000
Common Stock Shares Outstanding 444,200
Current Deferred Revenue11,168,000
Liabilities and Stockholders Equity 134,284,000
Net Debt 18,370,000
Net Invested Capital 115,518,000
Net Tangible Assets 18,358,000
Net Working Capital 21,352,000
Property Plant and Equipment Gross 26,284,000
Short Long Term Debt Total 29,282,000



Balance Sheet

Currency in ZAR. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-30
> Total Assets 
1,681,705
2,109,656
3,136,305
4,269,421
7,531,962
10,848,595
12,521,800
19,800,900
26,797,400
31,718,500
45,421,700
82,547,400
88,417,300
104,300,000
116,300,000
132,836,000
122,316,000
133,169,000
109,684,000
111,375,000
134,284,000
134,284,000111,375,000109,684,000133,169,000122,316,000132,836,000116,300,000104,300,00088,417,30082,547,40045,421,70031,718,50026,797,40019,800,90012,521,80010,848,5957,531,9624,269,4213,136,3052,109,6561,681,705
   > Total Current Assets 
827,978
1,136,742
1,393,720
2,149,626
5,139,265
4,759,466
5,600,800
7,622,600
9,374,300
10,431,900
15,777,000
31,212,800
32,737,100
37,200,000
38,100,000
40,222,000
36,152,000
36,738,000
32,705,000
34,561,000
44,500,000
44,500,00034,561,00032,705,00036,738,00036,152,00040,222,00038,100,00037,200,00032,737,10031,212,80015,777,00010,431,9009,374,3007,622,6005,600,8004,759,4665,139,2652,149,6261,393,7201,136,742827,978
       Cash And Cash Equivalents 
200,346
465,496
439,603
625,161
3,331,238
1,522,192
2,065,300
2,939,800
3,039,200
3,313,500
6,018,600
8,225,600
8,665,600
10,900,000
10,700,000
11,170,000
8,977,000
7,093,000
8,546,000
6,183,000
10,912,000
10,912,0006,183,0008,546,0007,093,0008,977,00011,170,00010,700,00010,900,0008,665,6008,225,6006,018,6003,313,5003,039,2002,939,8002,065,3001,522,1923,331,238625,161439,603465,496200,346
       Short-term Investments 
0
0
0
0
0
0
0
100
0
0
0
0
30,200
0
0
-940,000
234,000
6,000
9,000
318,000
0
0318,0009,0006,000234,000-940,0000030,20000001000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
9,246,500
9,800,000
8,800,000
13,170,000
12,844,000
12,095,000
12,886,000
10,437,000
14,615,000
13,624,000
13,624,00014,615,00010,437,00012,886,00012,095,00012,844,00013,170,0008,800,0009,800,0009,246,50000000000000
       Inventory 
213,527
245,676
425,879
798,303
936,761
1,446,961
1,434,600
2,041,400
2,628,100
3,292,000
4,100,900
10,275,200
10,791,500
14,400,000
13,600,000
14,496,000
14,648,000
16,413,000
13,409,000
15,763,000
19,606,000
19,606,00015,763,00013,409,00016,413,00014,648,00014,496,00013,600,00014,400,00010,791,50010,275,2004,100,9003,292,0002,628,1002,041,4001,434,6001,446,961936,761798,303425,879245,676213,527
       Other Current Assets 
414,105
425,570
528,238
726,162
871,266
1,790,313
2,100,900
2,641,300
3,707,000
3,826,400
5,657,500
12,712,000
13,249,800
11,900,000
13,800,000
14,556,000
12,527,000
13,232,000
10,750,000
-2,000,000
358,000
358,000-2,000,00010,750,00013,232,00012,527,00014,556,00013,800,00011,900,00013,249,80012,712,0005,657,5003,826,4003,707,0002,641,3002,100,9001,790,313871,266726,162528,238425,570414,105
   > Long-term Assets 
853,727
972,914
1,742,585
2,119,795
2,392,697
6,089,129
6,921,000
12,178,300
17,423,100
21,286,600
29,644,700
51,334,600
55,680,200
67,100,000
78,200,000
92,614,000
86,164,000
96,431,000
76,979,000
76,814,000
89,784,000
89,784,00076,814,00076,979,00096,431,00086,164,00092,614,00078,200,00067,100,00055,680,20051,334,60029,644,70021,286,60017,423,10012,178,3006,921,0006,089,1292,392,6972,119,7951,742,585972,914853,727
       Property Plant Equipment 
183,188
313,001
449,670
613,071
855,072
1,744,580
2,373,500
3,012,400
3,651,500
3,807,000
4,342,600
7,150,800
7,916,500
9,700,000
9,800,000
11,368,000
12,065,000
14,833,000
15,226,000
16,224,000
18,897,000
18,897,00016,224,00015,226,00014,833,00012,065,00011,368,0009,800,0009,700,0007,916,5007,150,8004,342,6003,807,0003,651,5003,012,4002,373,5001,744,580855,072613,071449,670313,001183,188
       Goodwill 
67,478
86,203
271,756
262,093
295,044
589,888
398,400
456,100
4,626,600
5,343,900
5,973,200
6,641,800
5,026,000
6,000,000
5,900,000
6,126,000
4,649,000
5,375,000
4,621,000
5,007,000
5,596,000
5,596,0005,007,0004,621,0005,375,0004,649,0006,126,0005,900,0006,000,0005,026,0006,641,8005,973,2005,343,9004,626,600456,100398,400589,888295,044262,093271,75686,20367,478
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
100
200,000
200,000
143,000
194,000
0
0
0
0
0
00000194,000143,000200,000200,00010000000000000
       Intangible Assets 
429,931
437,164
532,781
820,507
844,655
3,723,134
4,103,600
8,609,900
8,916,700
11,869,800
18,933,000
35,698,900
40,522,100
49,100,000
60,000,000
72,163,000
66,468,000
73,040,000
54,882,000
53,651,000
63,104,000
63,104,00053,651,00054,882,00073,040,00066,468,00072,163,00060,000,00049,100,00040,522,10035,698,90018,933,00011,869,8008,916,7008,609,9004,103,6003,723,134844,655820,507532,781437,164429,931
       Long-term Assets Other 
23,444
12,040
380,855
389,743
382,806
30,513
27,700
32,500
11,800
31,500
26,700
1,026,000
998,300
1,200,000
1,500,000
857,000
801,000
324,000
305,000
329,000
343,000
343,000329,000305,000324,000801,000857,0001,500,0001,200,000998,3001,026,00026,70031,50011,80032,50027,70030,513382,806389,743380,85512,04023,444
> Total Liabilities 
886,730
1,043,175
2,029,537
2,543,645
5,142,521
7,529,789
8,258,800
8,914,700
13,510,100
14,320,400
22,622,800
53,671,300
54,255,800
61,800,000
73,200,000
82,741,000
68,103,000
63,952,000
44,057,000
40,433,000
48,048,000
48,048,00040,433,00044,057,00063,952,00068,103,00082,741,00073,200,00061,800,00054,255,80053,671,30022,622,80014,320,40013,510,1008,914,7008,258,8007,529,7895,142,5212,543,6452,029,5371,043,175886,730
   > Total Current Liabilities 
607,376
774,796
1,491,229
1,954,396
4,630,058
6,884,742
4,220,400
5,829,900
8,207,900
7,320,300
12,865,300
16,042,000
21,778,500
21,100,000
34,800,000
28,209,000
20,039,000
18,079,000
36,751,000
23,395,000
23,148,000
23,148,00023,395,00036,751,00018,079,00020,039,00028,209,00034,800,00021,100,00021,778,50016,042,00012,865,3007,320,3008,207,9005,829,9004,220,4006,884,7424,630,0581,954,3961,491,229774,796607,376
       Short-term Debt 
0
0
0
0
0
0
2,670,300
3,720,800
5,138,000
4,127,100
8,152,700
8,075,300
13,222,200
10,900,000
18,900,000
11,225,000
8,248,000
6,302,000
24,608,000
11,665,000
7,907,000
7,907,00011,665,00024,608,0006,302,0008,248,00011,225,00018,900,00010,900,00013,222,2008,075,3008,152,7004,127,1005,138,0003,720,8002,670,300000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
37,993,000
11,400,000
10,900,000
18,900,000
8,171,000
8,234,000
6,112,000
24,443,000
10,329,000
7,907,000
7,907,00010,329,00024,443,0006,112,0008,234,0008,171,00018,900,00010,900,00011,400,00037,993,00000000000000
       Accounts payable 
336,380
353,442
595,376
713,104
646,857
1,003,968
1,300,200
1,913,900
2,830,800
2,929,200
4,174,600
6,884,000
3,429,200
8,300,000
5,200,000
4,487,000
3,928,000
3,369,000
3,297,000
3,641,000
3,969,000
3,969,0003,641,0003,297,0003,369,0003,928,0004,487,0005,200,0008,300,0003,429,2006,884,0004,174,6002,929,2002,830,8001,913,9001,300,2001,003,968646,857713,104595,376353,442336,380
       Other Current Liabilities 
270,996
421,354
895,853
1,241,292
3,983,201
5,880,774
249,900
195,200
239,100
264,000
538,000
1,082,700
5,127,100
1,900,000
10,700,000
374,000
325,000
421,000
351,000
346,000
104,000
104,000346,000351,000421,000325,000374,00010,700,0001,900,0005,127,1001,082,700538,000264,000239,100195,200249,9005,880,7743,983,2011,241,292895,853421,354270,996
   > Long-term Liabilities 
279,354
268,379
538,308
589,249
512,463
645,047
4,038,400
3,084,800
5,302,200
7,000,100
9,757,500
37,629,300
32,477,300
40,700,000
38,400,000
54,532,000
48,064,000
45,873,000
7,306,000
17,038,000
24,900,000
24,900,00017,038,0007,306,00045,873,00048,064,00054,532,00038,400,00040,700,00032,477,30037,629,3009,757,5007,000,1005,302,2003,084,8004,038,400645,047512,463589,249538,308268,379279,354
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,978,000
46,725,000
39,713,000
36,019,000
266,000
10,582,000
0
010,582,000266,00036,019,00039,713,00046,725,00028,978,00000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
7,713,800
7,000,000
8,000,000
9,418,000
7,807,000
8,351,000
9,854,000
7,040,000
6,456,000
3,525,000
3,525,0006,456,0007,040,0009,854,0008,351,0007,807,0009,418,0008,000,0007,000,0007,713,80000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
978,300
1,000,000
1,100,000
1,199,000
1,261,000
1,178,000
1,502,000
1,352,000
987,000
822,000
822,000987,0001,352,0001,502,0001,178,0001,261,0001,199,0001,100,0001,000,000978,30000000000000
> Total Stockholder Equity
787,611
1,066,481
1,106,768
1,700,814
2,375,517
3,196,604
4,182,700
10,831,000
13,226,200
17,389,400
22,793,800
28,874,200
34,138,700
42,500,000
43,100,000
50,067,000
54,211,000
69,215,000
65,627,000
70,942,000
86,236,000
86,236,00070,942,00065,627,00069,215,00054,211,00050,067,00043,100,00042,500,00034,138,70028,874,20022,793,80017,389,40013,226,20010,831,0004,182,7003,196,6042,375,5171,700,8141,106,7681,066,481787,611
   Common Stock
67,571
81,509
319,083
954,363
746,347
493,776
0
5,102,500
4,809,600
4,703,100
3,989,200
3,867,900
3,075,500
2,100,000
2,100,000
1,905,000
2,089,000
2,089,000
2,089,000
2,017,000
2,017,000
2,017,0002,017,0002,089,0002,089,0002,089,0001,905,0002,100,0002,100,0003,075,5003,867,9003,989,2004,703,1004,809,6005,102,5000493,776746,347954,363319,08381,50967,571
   Retained Earnings 
642,116
948,991
1,268,763
997,529
0
2,649,033
3,627,900
5,719,600
8,363,600
0
0
19,104,000
24,458,900
28,400,000
32,300,000
37,052,000
41,246,000
45,911,000
50,756,000
54,341,000
58,134,000
58,134,00054,341,00050,756,00045,911,00041,246,00037,052,00032,300,00028,400,00024,458,90019,104,000008,363,6005,719,6003,627,9002,649,0330997,5291,268,763948,991642,116
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
77,924
35,981
-481,078
-251,078
1,629,170
53,795
0
-153,100
-109,000
12,686,300
18,804,600
25,006,300
6,604,300
12,000,000
8,700,000
11,110,000
10,876,000
-48,000,000
-52,845,000
-56,358,000
-348,000
-348,000-56,358,000-52,845,000-48,000,00010,876,00011,110,0008,700,00012,000,0006,604,30025,006,30018,804,60012,686,300-109,000-153,100053,7951,629,170-251,078-481,07835,98177,924



Balance Sheet

Currency in ZAR. All numbers in thousands.




Cash Flow

Currency in ZAR. All numbers in thousands.




Income Statement

Currency in ZAR. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue40,709,000
Cost of Revenue-22,301,000
Gross Profit18,408,00018,408,000
 
Operating Income (+$)
Gross Profit18,408,000
Operating Expense-9,465,000
Operating Income7,822,0008,943,000
 
Operating Expense (+$)
Research Development214,000
Selling General Administrative1,677,000
Selling And Marketing Expenses2,922,000
Operating Expense9,465,0004,813,000
 
Net Interest Income (+$)
Interest Income509,000
Interest Expense-1,324,000
Other Finance Cost-0
Net Interest Income-815,000
 
Pretax Income (+$)
Operating Income7,822,000
Net Interest Income-815,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)6,555,0009,089,000
EBIT - interestExpense = 7,460,000
6,555,000
6,552,000
Interest Expense1,324,000
Earnings Before Interest and Taxes (EBIT)8,784,0007,879,000
Earnings Before Interest and Taxes (EBITDA)10,572,000
 
After tax Income (+$)
Income Before Tax6,555,000
Tax Provision-1,327,000
Net Income From Continuing Ops5,228,0005,228,000
Net Income5,228,000
Net Income Applicable To Common Shares5,228,000
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses31,766,000
Total Other Income/Expenses Net-1,267,000815,000
 

Technical Analysis of Aspen Pharmacare Holdings Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aspen Pharmacare Holdings Ltd. The general trend of Aspen Pharmacare Holdings Ltd is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aspen Pharmacare Holdings Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aspen Pharmacare Holdings Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 20,890 > 20,639 > 20,589.

Tweet this
Aspen Pharmacare Holdings Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aspen Pharmacare Holdings Ltd. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aspen Pharmacare Holdings Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aspen Pharmacare Holdings Ltd. The current macd is 311.81.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aspen Pharmacare Holdings Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Aspen Pharmacare Holdings Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Aspen Pharmacare Holdings Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Aspen Pharmacare Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAspen Pharmacare Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aspen Pharmacare Holdings Ltd. The current adx is 42.60.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Aspen Pharmacare Holdings Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Aspen Pharmacare Holdings Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aspen Pharmacare Holdings Ltd. The current sar is 22,463.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Aspen Pharmacare Holdings Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aspen Pharmacare Holdings Ltd. The current rsi is 51.58. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Aspen Pharmacare Holdings Ltd Daily Relative Strength Index (RSI) ChartAspen Pharmacare Holdings Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aspen Pharmacare Holdings Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Aspen Pharmacare Holdings Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Aspen Pharmacare Holdings Ltd Daily Stochastic Oscillator ChartAspen Pharmacare Holdings Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aspen Pharmacare Holdings Ltd. The current cci is -133.63508248.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Aspen Pharmacare Holdings Ltd Daily Commodity Channel Index (CCI) ChartAspen Pharmacare Holdings Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aspen Pharmacare Holdings Ltd. The current cmo is -14.57818985.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Aspen Pharmacare Holdings Ltd Daily Chande Momentum Oscillator (CMO) ChartAspen Pharmacare Holdings Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aspen Pharmacare Holdings Ltd. The current willr is -64.67702371.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Aspen Pharmacare Holdings Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Aspen Pharmacare Holdings Ltd Daily Williams %R ChartAspen Pharmacare Holdings Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aspen Pharmacare Holdings Ltd.

Aspen Pharmacare Holdings Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aspen Pharmacare Holdings Ltd. The current atr is 465.23.

Aspen Pharmacare Holdings Ltd Daily Average True Range (ATR) ChartAspen Pharmacare Holdings Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aspen Pharmacare Holdings Ltd. The current obv is 25,931,918.

Aspen Pharmacare Holdings Ltd Daily On-Balance Volume (OBV) ChartAspen Pharmacare Holdings Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aspen Pharmacare Holdings Ltd. The current mfi is 50.94.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Aspen Pharmacare Holdings Ltd Daily Money Flow Index (MFI) ChartAspen Pharmacare Holdings Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aspen Pharmacare Holdings Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Aspen Pharmacare Holdings Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aspen Pharmacare Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.577
Ma 20Greater thanMa 5021,956.450
Ma 50Greater thanMa 10020,776.660
Ma 100Greater thanMa 20020,125.830
OpenGreater thanClose21,500.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Aspen Pharmacare Holdings Ltd with someone you think should read this too:
  • Are you bullish or bearish on Aspen Pharmacare Holdings Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aspen Pharmacare Holdings Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aspen Pharmacare Holdings Ltd

I send you an email if I find something interesting about Aspen Pharmacare Holdings Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Aspen Pharmacare Holdings Ltd.

Receive notifications about Aspen Pharmacare Holdings Ltd in your mailbox!